Anagrelide Hydrochloride Capsule — FDA Drug Shortage

To Be Discontinued — Teva Pharmaceuticals USA, Inc.

The FDA lists a drug shortage record for Anagrelide Hydrochloride Capsule (capsule) from Teva Pharmaceuticals USA, Inc. with status To Be Discontinued. The shortage was first posted on Nov 19, 2025.

Shortage details

Status
To Be Discontinued
Company
Teva Pharmaceuticals USA, Inc.
Package NDC
0172-5241-60
Dosage Form
Capsule
Presentation
Anagrelide Hydrochloride, Capsule, 0.5 mg (NDC 0172-5241-60)
Initial Posting
Nov 19, 2025

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.